© Finnish Institute of Occupational Health – www.ttl.fi30.11.11
Well-being through work
© Finnish Institute of Occupational Health – www.ttl.fi30.11.11 2Mirja Kiilunen
Analysis of Cd and creatinine in urine Workshop on Quality of Analytical Data in HBM30.11.11, Brussels, Belgium Organized by WP 3 of COPHESMirja Kiilunen
© Finnish Institute of Occupational Health – www.ttl.fi30.11.11 3Mirja Kiilunen
Outline
• Problems with sample, samples storage, shipping etc.
• Choice of method• AAS• ICP-MS
• Creatinine measurements• Modification of Jaffe’s
© Finnish Institute of Occupational Health – www.ttl.fi30.11.11 4Mirja Kiilunen
Problems for sample
• Sample collection• Dilute samples• Wrong sampling time
• Sample Storage• Shipping
• Sample preparation
• Analysis
• Interpretation
© Finnish Institute of Occupational Health – www.ttl.fi30.11.11 5Mirja Kiilunen
Sample Transport and Storage
• Losses• Absorption• Precipitation• Degradation
• Stability• Storage temperature• Storage time• Growth - preservative ?
• Shipment
© Finnish Institute of Occupational Health – www.ttl.fi30.11.11 6Mirja Kiilunen
Urinary Cadmium - sampling
• Special-washed laboratory ware is required for successful specimen collection
• Also clean collection cup • After shower or washing hands and the urethral
orifice and change to street clothes • No preservatives
• Sampling time is not critical for cadmium• Dilute samples
• creatinine in urine of adult working Finns is 13 mmol/l urine equate relative density 1,021
© Finnish Institute of Occupational Health – www.ttl.fi30.11.11 7Mirja Kiilunen
Guideline for sampling U-Cd
Exposure Cadmium and inorganic cadmium compounds
Specimen 20 ml of urine. Special-washed containers have to be used, and no preservatives may be added. If the urine sample is voided to a disposable vessel, it has to be transferred immediately to the special-washed sample container. The laboratories of the Institute of Occupational Health provide special-washed sample containers.
Sampling time Specimen can be collected at any time of the day
Storage and transport The specimen is stored in a refrigerator and sent so that it reaches the laboratory before the week-end. Specimens collected toward the end of the week are preferably kept in the refrigerator over the week end and sent on Monday.
Sources of error Specimen is prone to contamination. Dust from the work place air, or skin or clothing of the workermay contaminate the specimen. The specimen is collected after the worker has showered (or washed hands and the urethral orifice) and changed to street clothes.
Note The concentration of antimony, beryllium, chromium, cobalt, lead, manganese, molybdenum, nickel, selenium, thallium and vanadium may be determined from the same 20-ml specimen if the sampling time is after shift.
Reference limit for non-exposed
Non-smokers 5 nmol/l.Smokers 10 nmol/l.
Biomonitoring action limit
40 nmol/l.The European Union has classified several cadmium compounds as carcinogenic, mutagenic or hazardous to reproduction (Cat. 2 or 3; R45, R63, and R68, H340, H341, H350, H360FD, H351fd). The Finnish Government Decree 1335/2004 stipulates that exposure to chemicals in these categories is not acceptable during pregnancy, i.e., the urine cadmium concentration must not exceed the reference limit for non-exposed 5 nmol/l (non-smokers) or 10 nmol/l (smokers).
www.ttl.fi/biomonitoring
© Finnish Institute of Occupational Health – www.ttl.fi30.11.11 8Mirja Kiilunen
Analysis of cadmium in urine
• Colorimetric methods Diphenylthiocarbazoneand dithizone – CHCl3
• a suitable method should measure 0-20 μg Cd in 50 ml urine and be sensitive to 0.1 μg Cd. ~ 400 μg/l ~3.6 μmol/l
• Great problems from other metals Cu++ >30 μg prevent detection of Cd. Pre-extraction with dithizone – CHCl3 fromacidified solution and Cd from basic solution afterwards.
• Dithizone was also photolabile – prevention NH4 , KCN• Two prewashings of dithizone solutions• Acid digest of urine on sand bath followed by three different
kind of extraction processes• Colorimetric measurement at 506 nm• 12 urine samples + 2 blanks at a time• Lowest concentrations detected 9 μg/l ~85 nmol/l
SMITH et al. Biochem J. 1955 Dec;61(4):698–701 .
© Finnish Institute of Occupational Health – www.ttl.fi30.11.11 9Mirja Kiilunen
Analysis of cadmium in urine
Atomic absorption flame technique• metals extracted as iodide complexes with tri-
n-octylamine in n-butyl acetate• without elaborate pretreatment, direct
nebulization into an air/ acetylene flame• Detection limits for cadmiumin urine
0.008×10 6 mol/l ~ 0,8 nmol/l• No information of control samples
Flanjak, J, Hodda, A. (1985) Analytica Chimnica ActaVol 172:313-316
© Finnish Institute of Occupational Health – www.ttl.fi30.11.11 10Mirja Kiilunen
Different derivate flame techniques• Delves cup and other derivate techniques
Urine samples 100 ml digested on an electric hot-plate with HNO3, HCIO4 for 1 hour, residue dissolved into HNO3
Concentrated on a water-cooled stainless steel atom trapping tubeDL 0.02 μg/l~0.2 nmol/l
The absorption signals of conventional AT-FAAS (l) and D-AT-FAAS (II)
Sun Han-Wen et al. (1997) Spectrochimica Acta Part B 52 727-734
© Finnish Institute of Occupational Health – www.ttl.fi30.11.11 11Mirja Kiilunen
Flameless Atomic absortion
• ‘Reference method’ for urinary cadmium measurements
• Ammoniumpyrrolidine hexamethylenedithiocarbamate (APDC)/MIBK + FAAS
• DL 0,2 μg/l ~ 2 nmol/l
Angerer in Analyses of Hazardous Substances in Biological Materials,Vol 2, VCH, 1988, 85-96
© Finnish Institute of Occupational Health – www.ttl.fi30.11.11 12Mirja Kiilunen
Flameless AAS
• Standard addition method• Dilution 1:3 with nitric acid• Modifier Ammonium oxalate
• Detection limit 0.01 μg/l ~ 0.1 nmol/l
Kiilunen, M., Aitio, A. (1990) International symposium on trace elements in health and disease., 5.-8.6. Espoo, Finland
© Finnish Institute of Occupational Health – www.ttl.fi30.11.11 13Mirja Kiilunen
InductivelyCoupled Plasma Atomic Emission Spectrometry ICP-AES (OES)
• 1,5-bis(di-2-pyridylmethylene)thiocarbonohydrazide extraction into isobutyl methyl ketone
• Critical effects: pH, concentration of extractant, shaking time and ionic strength
• Detection limit 0.1 μg/l ~0,9 nmol/l• Linear area 0.2 -140 μg/l, CV 2,9 % for 2 μg/l
Espinosa Almendro et al, ANALYST, 1992, VOL. 117, 1749-51
© Finnish Institute of Occupational Health – www.ttl.fi30.11.11 14Mirja Kiilunen
ICP-AES
• Purification of samples with activated charcoal under acidic conditions
• preconcentration APDC /MIBK• the resulting residue is finally digested under acid
oxidant conditions • detection limit (below 10 μg/l)• this procedure can be applied conveniently for
toxicological diagnostic purposes
• Also phase extraction methods are used• Internal standards to ensure reproducibility
López-Artiquez et al. (1993) J Anal Toxicol 17(1):18-22.
© Finnish Institute of Occupational Health – www.ttl.fi30.11.11 15Mirja Kiilunen
Validation of the method
Selectivity and specificity• AAS the emission spectrum – resonance line
• a definite frequency or definite frequencies; second-degree line
• ICP-MS Mass-to-charge ratio m/z
• ICP-OES >< ICP-MS 48Cd Detection limits• 5 μg/l solution ICP-OES• 0.0005 μg/l solution ICP-MS• 2.5 μg/l solid ICP-OES• 0.01 μg/l solid ICP-MS
(theoretical best case scenarios)
© Finnish Institute of Occupational Health – www.ttl.fi30.11.11 16Mirja Kiilunen
Validation of the method
• range of measurement and linearity
• Important, if wide concentration range
• ICP – huge, AAS - limited
• In practise range of standards - dilutions
© Finnish Institute of Occupational Health – www.ttl.fi30.11.11 17Mirja Kiilunen
Validation of the method
Sensitivity
AAS• the Lambert–Beer law
• A= * l* c• = molar absortivity, l = length of cuvette
ICP-MS• c/s = (BLANK + a + b*conc)*[I/S Ratio].
© Finnish Institute of Occupational Health – www.ttl.fi30.11.11 18Mirja Kiilunen
AAS >< ICP-MS
0 5 10 15 20-2
0
2
4
6
8
10
12
14
16
18
ICP
-MS
μg/
l
AAS μg/l
Y = 0.068 + 0.934 * XR = 0.995 N=50 P<0.0001
© Finnish Institute of Occupational Health – www.ttl.fi30.11.11 19Mirja Kiilunen
Validation of the method
limit of detection LOD • detection limit, is the lowest concentration level
that can be determined to be statistically different from a blank (99% confidence)
• X ± 3*sdlimit of quantitation LOQ • lower limit of quantitation (LOQ), is the level
above which quantitative results may be obtained with a specified degree of confidence.
• X ± 6*sd
© Finnish Institute of Occupational Health – www.ttl.fi30.11.11 20Mirja Kiilunen
Validation of the method
• Method interferences• AAS
• Matrix effects, chemical effects, spectral interferencesminor physical and ionisation (GAAS)
• ICP-MS• Argon, nitrogen, oxygen, chlorine and hydrogen, and
their constituent compounds• Spectral disturbances caused by occultation• Spectral errors due to mono-and polyatomisista ions -
isobaric disturbances• Matrix effects
© Finnish Institute of Occupational Health – www.ttl.fi30.11.11 21Mirja Kiilunen
Validation of the method
Precision• a series of repeated measurements of the same
parameter (External quality control or spiked samples)
Repeatability• a series of repeated preparations and
measurements of the same parameter within a sample
• Different concentration levels on range of measurement
• measurement uncertainty
© Finnish Institute of Occupational Health – www.ttl.fi30.11.11 22Mirja Kiilunen
Plasmas
• A sample solution is introduced into core of inductively coupled argon plasma (ICP)
• 8000 °C
• OES: All elements thermally excited and emit light at their characteristic wavelenghtsthrought diffraction grating amplified signal
• MS: plasma generates ions mass analyzermass to charge ratio
© Finnish Institute of Occupational Health – www.ttl.fi30.11.11 23Mirja Kiilunen
Inductively Coupled Plasma Spectrometry techniques
Strengths Limitations
Up to 70 elements can be determinatedsimultaneously
The emission spectra are complex and inter-element inferences are possible – wavelength very close to that another element.
The useful working range is over several orders of magnitude
MS. Common matrix elements and other molecular species can interfere with the measurement of some elements. Doubly charged or molecular ionic species can create difficulties in quantifications.
Instrument suitable to automation, thus enhancing accuracy, precision and throughput.
The sample to be analyzed must be digested or at least diluted prior to analysis in order to dissolve the elements of interest.
© Finnish Institute of Occupational Health – www.ttl.fi30.11.11 24Mirja Kiilunen
Cadmium and Tin interferences
111Cd
112Cd -0.04000 * 118Sn
114Cd -0.02700 * 118Sn
© Finnish Institute of Occupational Health – www.ttl.fi30.11.11 25Mirja Kiilunen
Standard curves
© Finnish Institute of Occupational Health – www.ttl.fi30.11.11 26Mirja Kiilunen
Do not use Cd 108 and 110
© Finnish Institute of Occupational Health – www.ttl.fi30.11.11 27Mirja Kiilunen
Creatinine
• Creatinine is a waste product of muscle creatine
• The amount of creatinine produced is related to body weight
• It does not vary greatly from day to day
• Within subject variation4.3 %
Creapure®
© Finnish Institute of Occupational Health – www.ttl.fi30.11.11 28Mirja Kiilunen
Creatinine and diet
Hoogwerf BJ, Lame DC, Greene, E (1986) Am J Clil Nut 43: 350-360.
© Finnish Institute of Occupational Health – www.ttl.fi30.11.11 29Mirja Kiilunen
Jaffe’s reaction
• Creatinine + Picric acid Alkaline pH Yellow complex• absorbs at 510 nm
• Any compound that reacts with picrate in alkali conditions e.q. protein, glucose
Jaffe M. Ueber den Niederschlag welchen Pikrinsäure in normalen Harnerzeugt und ueber eine neue Reaktion des Kreatinins. Z Physiol Chem 1886;10:391-400
© Finnish Institute of Occupational Health – www.ttl.fi30.11.11 30Mirja Kiilunen
Modifications
• Deproteinisation to improve specificity• Absorption on aluminium silicates to remove
interferents followed by elution into alkaline picrate
• At a neutral pH only the interferents reacts
• Automatisation started on 1960’s• Continous flow technology• Removing protein, bilirubin, not glucose.
© Finnish Institute of Occupational Health – www.ttl.fi30.11.11 31Mirja Kiilunen
Entsymatic reactions
At 670 nm
Interferences: creatine, proline, dobutamin, lidocaine
© Finnish Institute of Occupational Health – www.ttl.fi30.11.11 32Mirja Kiilunen
VITROS is a trademark of Ortho-Clinical Diagnostics, Inc.© Ortho-Clinical Diagnostics, Inc., 2007.
Preservatives – no interferences
Effect < 2% on creatinine results• Thymol• Toluene• Boric acid• Glacial acetic acid (0.5 to 1.0 v/v)• 12N HCl• NH4OH• Bromide• Iodide• 5% NaOH
© Finnish Institute of Occupational Health – www.ttl.fi30.11.11 33Mirja Kiilunen
Problems with kits
Creatinine (urinary) Assay Kit Item No. 500701©06/22/2011, Cayman Chemical Company
Intra-assay CV = 2.7% (n = 84)Inter-assay CV = 3% (n = 5)
© Finnish Institute of Occupational Health – www.ttl.fi30.11.11 34Mirja Kiilunen
Sample kit Vitros
© Finnish Institute of Occupational Health – www.ttl.fi30.11.11 35Mirja Kiilunen
HPLC methods
• Diluted urine + acetonitrile containing phenacetin(internal standard) centrifugated supernate directly into the chromatograph
• Isocratical liquid chromatography• mobile phase of acetonitrile and aqueous KH2PO4
Sample 1 Sample 2 Sample 3
X mg/l 407 814 1157
SD mg/l 5.4 21.9 21.6
CV% 1.3 2.7 1.9
Between-day (n=6, each run on 12 days)
Okuda, T, Ole, T, Nishida, M (1983) CLIN.CHEM. 29/5,851-853
© Finnish Institute of Occupational Health – www.ttl.fi30.11.11 36Mirja Kiilunen
Creatinine in urine –microtitreplates – Jaffé method 492 nm
Concentration level Control Intra-assay repeatability(N=10)
1.6% or 1.6 % 0.79g/l or 1.71 g/l Duotrol®Standard deviation (rel.) 2.1% or 2.5 % 0.72 g/l or 1.40 g/l Quantimetrix®
3.6% or 3.6 % 0.79g/l or 1.71 g/l Duotrol®Confidence interval 4.7 % or 5.7 % 0.72 g/l or 1.40 g/l Quantimetrix®
Inter-day repeatability (N=6) 1.5% or 1.4 % 0.80g/l or 1.72 g/l Duotrol®Standard deviation (rel.) 1.4% or 2.2 % 0.72 g/l or 1.40 g/l Quantimetrix®
3.9% or 3.6 % 0.80g/l or 1.72 g/l Duotrol®Confidence interval 3.6 % or 5.7 % 0.72 g/l or 1.40 g/l Quantimetrix®
Accuracy (N=8) 107.9 % or 102.6% 0.72g/l or 1.66 g/l* Duotrol® Recovery rate 93.7 % or 84.6 % 0.78 g/l or 1.63 g/l* Quantimetrix®
Detection limit <0.125 g creatinine per litre urine *theoretical values
Blaszkewicz and Liesenhoff-Henze MAK-Collection for Occupational Health and Safety 2010
© Finnish Institute of Occupational Health – www.ttl.fi30.11.11 37Mirja Kiilunen
Creatinine – Jaffe’s method
Principle of the method• Creatinine present reacts with alkaline picrate
resulting in the formation of a red colour
• the intensity is measured at 505nm/green filter• protein interference elimination: sodium lauryl
sulphate• A second absorbance reading after acidifying with
30% acetic acid corrects for non-specific chromogens in the samples.
Fossati,P, Ponti,M, Passoni,G, Tarenghi, G, Meizi d’Eril, GV, Prencipe, L (1994) CLIN. CHEM. 40/1, 130-137
© Finnish Institute of Occupational Health – www.ttl.fi30.11.11 38Mirja Kiilunen
Enzymatic method – with iminohydralase
measured at 340 nm the consumption of NADPH (reduced Nicotinamide Adenine Dinucleotide Phosphate)
Fossati,P, Ponti,M, Passoni,G, Tarenghi, G, Meizi d’Eril, GV, Prencipe, L (1994) CLIN. CHEM. 40/1, 130-137
• Hydrolysation by creatinine iminohydrolaseto ammonia and N-methylhydantoin.
• Consumption of NADPH, is proportional to the amount of creatinine in the sample.
• The first step eliminates background absorbance
• The second step starts creatinine measurement.
© Finnish Institute of Occupational Health – www.ttl.fi30.11.11 39Mirja Kiilunen
Creatinine urine comparison
Fossati,P, Ponti,M, Passoni,G, Tarenghi, G, Meizi d’Eril, GV, Prencipe, L (1994) CLIN. CHEM. 40/1, 130-137
Present methodinstrument
ComparisonmethodInstrument
n slope X Y Bias % r
TechniconRA-XT
Jaffékinetic/RA-XT
60 1.001 13.7 13.9 0.2(1.4) 0.998
TechniconRA-XT
EntsymaticPAP/Cobas Fara
87 1.015 13.8 14.2 0.4(2.9) 0.996
Hitachi 717 Fuller’searth
60 1.024 4.6 4.9 0.3(6.5) 0.998
© Finnish Institute of Occupational Health – www.ttl.fi30.11.11 40Mirja Kiilunen
Three different enzymatic methods
Badiou, S, Dupuy, A.M. Descomps, B, Cristol, JP (2003) J Clinl Lab Anal 17:235–240
© Finnish Institute of Occupational Health – www.ttl.fi30.11.1112.12.2011 41Mirja Kiilunen
Comparison – different methods instruments
© Finnish Institute of Occupational Health – www.ttl.fi30.11.11 42Mirja Kiilunen
Enzymatic creatinineinterferences and limitations
• Entzymatic reactions are more specific for creatinine
• Many interferences depending the concentrations
© Finnish Institute of Occupational Health – www.ttl.fi30.11.11 43Mirja Kiilunen
Ion-exchange methods
• Different commercial batches of Fuller's earth (cation exchange )
• Incomplete adsorption of creatinine• Depends on pH, temperature, concentration of
cations as Ca2+ and Na+
• Weakly acidic suspensions change their ability to adsorb creatinine
• Synthetic strong acidic cation exchanger more selective to creatinine
Egense, Koch Willems (1990) Scand J Clin Lab Invest. 50(6):687-92.
© Finnish Institute of Occupational Health – www.ttl.fi30.11.11 44Mirja Kiilunen
GC-IDMS – methodsisotope dilution mass spectrometry
• Standard Reference Material 909 of the National Institute of Standards and Technology
• Excellent specificity and relative SD <0.3%• Creatinine is derivatized before GC analysis
because of its polarity• A cation-exchange clean-up step before GC
analysis to remove creatine
• HPLC with IDMS• a simple protein precipitation without
derivatization bias <0.2% and an expanded uncertainty <0.3% (k = 2)
•Stockl and Reinauer (1993) Clinical Chemistry 39: 993-1000.
© Finnish Institute of Occupational Health – www.ttl.fi30.11.11 45Mirja Kiilunen
Reference materials
• NIST SRM 967 two levels 66 and 347 μmol/l
Manufacturer Reagent (Product Number)
Abbott Diagnostics Creatinine (7D64)
Abbott Diagnostics Creatinine (7D64)
Abbott Diagnostics Creatinine, Next Generation (3L81)
Beckman Coulter, Inc. CREA (442760)
Beckman Coulter, Inc. CREA (442760)
Beckman Coulter, Inc. Creatinine (443340)
Beckman Coulter, Inc. CREm (472525)
Dade Behring, Inc. Dimension® CREA Flex (DF33A)
Olympus Diagnostics Systems Creatinine (OSR6178)
Olympus Diagnostics Systems Creatinine (OSR6178)
Ortho Clinical Diagnostics CREA Slides (814 1947)
Roche Diagnostic Corporation CREA plus (11775642)
Roche Diagnostic Corporation CREA/RB (12217333)
Siemens Diagnostics Creatinine_2 (B01-4126-01)
Siemens Diagnostics Creatinine Enzymatic (B01-4127-01)
© Finnish Institute of Occupational Health – www.ttl.fi30.11.11 46Mirja Kiilunen
QC round LABQUALITY
© Finnish Institute of Occupational Health – www.ttl.fi30.11.11 47Mirja Kiilunen
U-Creat mmol/l
Method Mean SD CV% Number of results
Photometric, Jaffe 12.6 0.8 6.2 53
Photometric enzymatic 12.4 0.6 4.7 48
Vitros 11.1 0.8 7.3 8
Method unknown 12.6 0.1 1.1 2
All together 12.4 0.8 6.3 111
© Finnish Institute of Occupational Health – www.ttl.fi30.11.11 48Mirja Kiilunen
Thank You!
48